Interaction of poly(styrene sulfonic acid) with the classical pathway of the serum complement system.

Interaction of poly(styrene sulfonic acid) with the classical pathway of the serum complement system. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Interaction of poly(styrene sulfonic acid) with the classical pathway of the serum complement system. Abstract Text:

Yoshinobu Murakami,Hiroo Iwata,Etsuko Kitano,Hajime Kitamura,Yoshito Ikada,

Bioartificial pancreas, in which the islets of Langerhans (islets) are enclosed in artificial membrane to be protected from the host immune system, is expected to be a promising medical device to treat patients who suffer from insulin-dependent diabetes. Our strategy for the preparation of a bioartificial pancreas involves utilizing a membrane including polymeric materials that can inhibit the complement. When we examined a membrane containing poly(styrene sulfonic acid), long survival of islets enclosed in the membrane was observed in recipients carrying antibodies against islet cells. This fact stimulated us to start examinations of effects of PSSa on the complement system. In this study, we examined effects of PSSa on the classical pathway (CP) of the serum complement system to identify the mechanism(s) involved. The electric static interaction between cationic C1q (pI 9.3) and anionic PSSa induces PSSa-C1q complex formation. The dissociation of C1q(r2s2) complex by PSSa results inactivation of the CP activity. Those results indicate that PSSa was not an activator of the CP, but an inhibitor of CP activation. This study clarifies the mechanism by which PSSa protects islets in a microcapsule from the humoral immunity of the recipient carrying anti-islet antibodies. A microcapsule containing PSSa seems to effectively protect the islet from attacks of the host immune system after transplantation carrying antibodies against islet cells.

Interaction of poly(styrene sulfonic acid) with the classical pathway of the serum complement system. Publishing Authors By Initials

Y Murakami,H Iwata,E Kitano,H Kitamura,Y Ikada,

For similar biochemical phenomena, metabolism, and nutrition: biochemical phenomena: protein binding research abstracts see: biochemical phenomena, metabolism, and nutrition: biochemical phenomena: protein binding research

PUBMED ID PMID:

MEDLINE DATE:

Interaction of poly(styrene sulfonic acid) with the classical pathway of the serum complement system. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Journal of biomaterials science. Polymer edition

VOLUME: 16

Page Numbers: 685-97

Journal Abbreviation:

ISSN: 0920-5063

DAY: 20

MONTH: 02

YEAR: 2005

Interaction of poly(styrene sulfonic acid) with the classical pathway of the serum complement system. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9007393

Interaction of poly(styrene sulfonic acid) with the classical pathway of the serum complement system. Keywords Mesh Terms:

KEYWORDS: Protein Binding

MESH TERMS: pharmacology

Chemical & Substance for Abstract: Interaction of poly(styrene sulfonic acid) with the classical pathway of the serum complement system. Information

Substance Name: Complement C1q

Registry Number: 80295-33-6

Grant and Affiliation Information for Interaction of poly(styrene sulfonic acid) with the classical pathway of the serum complement system.

AFFILIATION: Institute for Frontier Medical Sciences, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Biomater Sci Polym Ed

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Interaction of polystyrene sulfonic acid with the classical pathway of the serum complement system Related Publications

• A bioabsorbable delivery system for antibiotic treatment of osteomyelitis. The use of lactic acid oligomer as a carrier.
• Alveolar bone regeneration using absorbable poly(L-lactide-co-varepsilon-caprolactone)/beta-tricalcium phosphate membrane and gelatin sponge incorporating basic fibroblast growth factor.
• An immuno-isolative membrane capable of consuming cytolytic complement proteins.
• Bone formation at a rabbit skull defect by autologous bone marrow cells combined with gelatin microspheres containing TGF-beta1.
• Controlled release of vascular endothelial growth factor by use of collagen hydrogels.
• Cross-linking of amniotic membranes.
• Depressed tuberculin sensitivity in Darier's disease.
• Depressed tuberculin sensitivity in porokeratosis.
• Dextran sulfate as a material for the preparation of a membrane for immunoisolation.
• Ectopic bone formation induced by biodegradable hydrogels incorporating bone morphogenetic protein.
• Encapsulation of mammalian cells into synthetic polymer membranes using least toxic solvents.
• Enzyme-catalyzed synthesis of a bioactive oligopeptide in nearly anhydrous solvents with polyethylene glycol-modified proteases.
• Fusogenic activity of various water-soluble polymers.
• In vivo chondrogenesis in collagen sponge sandwiched by perichondrium.
• Influence of gelatin complexation on cell proliferation activity and proteolytic resistance of basic fibroblast growth factor.
• Interaction of poly(2-acrylamido 2-methylpropane sulfonate)-grafted polystyrene beads with cationic complement proteins.
• Interaction of poly(styrene sulfonic acid) with the alternative pathway of the serum complement system.
• Interaction of poly(styrene sulfonic acid) with the classical pathway of the serum complement system.
• Letter: Hyperkeratosis lenticularis perstans.
• Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibroblast growth factor.
• New biodegradable oligoesters for pharmaceutical application.
• New detachable balloon technique for traumatic carotid-cavernous sinus fistulae.
• Preparation of DNA-immobilized immunoadsorbent for treatment of systemic lupus erythematosus.
• Regeneration of extrahepatic bile duct -possibility to clinical application by recognition of the regenerative process.
• Regeneration of the inferior vena cava with a bioabsorbable polymer implant: a histological study.
• Soft tissue adhesive composed of modified gelatin and polysaccharides.
• Spatial gradient effects of 120 mT static magnetic field on endothelial tubular formation in vitro.
• Surface modification of silicone for percutaneous implantation.
• Treatment of a spontaneous carotid cavernous fistula using an electrodetachable microcoil.
• Vascularization into a porous sponge by sustained release of basic fibroblast growth factor.